The Scientific Committee of IMPE 2027 cordially invites clinicians, researchers, and healthcare professionals in pediatric endocrinology and related fields to submit abstracts for presentation at IMPE 2027, to be held from September 23 to 26, 2027, at PACIFICO Yokohama North, Yokohama, Japan.
Presenting your work at IMPE 2027 offers an excellent opportunity to share your latest research with the international pediatric endocrinology community, receive valuable feedback, exchange knowledge, and foster international collaboration.
All abstracts will be peer-reviewed by the Scientific Committee. Accepted abstracts will be assigned to either an oral presentation or a poster presentation. The final presentation format will be determined by the Scientific Committee.
All abstract submissions must be made electronically through the IMPE 2027 online abstract submission system.

Abstract Topics

Please select the most appropriate topic for your abstract from the following categories:

• Adrenals and HPA Axis
• Bone, Growth Plate and Mineral Metabolism
• Diabetes and Insulin
• Fat, Metabolism and Obesity
• Fetal, Neonatal Endocrinology and Metabolism
• GH and IGFs
• Growth and Syndromes
• Multisystem Endocrine Disorders
• Pituitary, Neuroendocrinology and Puberty
• Sex Differentiation, Gonads and Gynecology, and Sex Endocrinology
• Thyroid
• Others

The Scientific Committee reserves the right to reassign an abstract to a different topic category if deemed appropriate.

Submission Instructions

1. Abstracts must be submitted online through the IMPE 2027 abstract submission system. Abstracts submitted by email, fax, or other means will not be accepted.
2. Abstracts must be submitted by the announced submission deadline. Abstracts received after the deadline will not be considered.
3. The person submitting the abstract will be considered the presenting author.
4. The presenting author is responsible for ensuring that all co-authors have reviewed and approved the abstract and agreed to its submission.
5. All abstracts will be reviewed by the Scientific Committee.
6. Acceptance or rejection of an abstract and the final presentation format will be determined by the Scientific Committee.
7. Presenting authors will be notified of the review results by email.
8. Failure to complete registration by the designated deadline may result in the withdrawal of the abstract from the scientific program.

Presentation Format

Abstracts may be selected for either:

• Oral Presentation
• Poster Presentation

Authors may indicate their preferred presentation format during abstract submission, if applicable. However, the final presentation format will be determined by the Scientific Committee based on the results of the peer-review process and the overall scientific program.
Detailed presentation guidelines, including presentation duration and poster specifications, will be announced after notification of acceptance.

Language

All abstracts must be submitted in English.
All oral and poster presentations must also be given in English.
Authors are responsible for ensuring that their abstracts are written in clear, grammatically correct English and are suitable for publication.
Neither the Scientific Committee nor the IMPE 2027 Secretariat provides proofreading or language-editing services.

Title

The abstract title must not exceed 150 characters.
The title should clearly and concisely describe the content of the study.

Abstract Text

The abstract text must not exceed 350 words.
Please ensure that the abstract clearly presents the purpose, methods, results, and conclusions of the study, as appropriate.

Authors

A maximum of 20 authors, including the presenting author, may be listed for each abstract.
The presenting author must ensure that the names, affiliations, and other information of all co-authors are entered correctly.

Figures and Tables

Authors may upload up to two supplementary figures, tables, or graphs through the abstract submission system, if permitted.
Up to 2 accompanying data (figures, tables or graphs) can be uploaded.

Authors are responsible for ensuring that they have permission to use any copyrighted material included in their submission.

Encore Presentation/Originality

Abstracts describing research previously presented at another scientific meeting or published elsewhere may also be submitted to IMPE 2027.
However, the acceptance or rejection of such abstracts will be determined by the Scientific Committee.
Authors are encouraged to submit abstracts containing new data, updated analyses, additional findings, or new perspectives whenever possible.
The Scientific Committee reserves the right to determine whether a submitted abstract provides sufficient scientific value and originality for presentation at IMPE 2027.

Review and Selection

All submitted abstracts will undergo peer review by the Scientific Committee.
Abstracts will be evaluated based on scientific quality, relevance, originality, clarity, and significance to the field of pediatric endocrinology.
Based on the review results, abstracts may be:

• Accepted for oral presentation;
• Accepted for poster presentation; or
• Not accepted.

The Scientific Committee will make the final decision regarding acceptance and presentation format.
All decisions made by the Scientific Committee are final.

Conflict of Interest (COI)COI Disclosure Form

All authors, including the presenting author and co-authors, are required to disclose any relevant conflicts of interest during the abstract submission process. The presenting author is responsible for ensuring that COI information has been provided for all authors.

Important Notes

Before submitting an abstract, please ensure that:

• All information entered in the submission system is correct.
• All co-authors have reviewed and approved the abstract.
• All co-authors have agreed to be listed as authors.
• All necessary ethical approvals and informed consent, where applicable, have been obtained in accordance with relevant institutional and national requirements.
• The abstract does not contain information that violates patient confidentiality.
• Any potential conflicts of interest have been appropriately disclosed.

The presenting author is responsible for the accuracy and integrity of the submitted abstract.

Modification and Withdrawal

Authors may edit their abstracts through the online submission system until the abstract submission deadline.
Changes to abstracts, author information, or affiliations will generally not be accepted after the submission deadline.
Requests to withdraw an abstract should be submitted to the IMPE 2027 Secretariat. Please include the abstract number, title, and presenting author's name in your request.

Copyright

By submitting an abstract to IMPE 2027, authors grant the organizers permission to publish accepted abstracts in the congress program, abstract book, on the official website, in the mobile application, and in other official IMPE 2027 materials.
Details regarding copyright and publication rights will be provided in the abstract submission system.

Contact

For further information regarding abstract submission and presentation, please contact:

IMPE 2027 Secretariat
Convention Linkage, Inc.
2 Sanbancho, Chiyoda-ku, Tokyo 102-0075, Japan
E-mail: impe2027-abs@c-linkage.co.jp

Submit Abstract
(Create your account first)

AI翻訳サポートのご案内
Japanese-English AI translation platform